Proven Track Record of Most Accurate Analysis
Proven Track Record
of Most Accurate Analysis
Novavax (NVAX) is running up as FAO of the United Nations has urged more readiness against a possible resurgence of Bird Flu. According to the United Nations a mutant strain of Bird Flu is spreading bird flu virus in Asia. Novavax makes a vaccine against the Bird Flu. If and when six screens of the ZYX Change Method are satisfied, we will issue a buy signal on the Real Time Feed of the ZYX Buy Change Alert.
Adding to our silver (SI) futures short position at $41.50. Equivalent on silver etf (SLV) is $$40.43.
It is time to add another 5% tranche to gold (GLD) right here at $178.12. In view of Consumer Confidence falling to 44% compared to expectations of 52%, stock market is showing a very impressive performance.Lately gold , for the most part has moved inversely to the stock market. Updates are available on this position in real-time on the Real Time Feed of the ZYX Short Sell Change
Taking partial profits on a 5% QQQ (QQQ) tranche right here at $$54.39. We are closely following this trade in the Real Time Feed of the ZYX Buy Change Alert
We are short selling a 5% tranche on gold GLD right here at $177.51. We will not use a stop but keep the quantity small to control the risk. Target is $165. We will be closely following this trade on gold in the Real Time Feed of the ZYX Short Sell Change Alert.
SAP (SAP) is strong today because Jim Cramer recommended SAP on his show. When Jim Cramer recommends a stock such as SAP, it is usually best to sell into the hype, wait for a pull back and then buy if appropriate. The point is that those inclined to buy SAP may consider waiting for a pull back in SAP stock.
SAP AG (SAP) and Oracle (ORCL) hold a duopoly in providing Enterprise Resource Planning systems to large corporations. SAP last quarter earnings were excellent and projections were great. It is important to understand that when a software company such as SAP states that it sees great visibility, it usually means that they have signed contracts in hand but cannot book revenues yet. There is some apprehension on wall street regarding future earnings for Oracle. The reason is slowness in the government sector. From a risk reward perspective, Oracle offers a better opportunity at
Omnivision (OVTI) reported earnings better than expected, but projections were a disaster. Omnivision sees Q2 EPS 52c-64c vs. consensus 82c Omnivision sees Q2 revenue $255M-$275M vs. consensus $306.37M . There is speculation that lower projections are the result of losing some Apple (AAPL) camera business to Sony (SNE). In any case, this dip is a buying opportunity. We bought a 5% tranche at $17.07 in the after market. We will be closely following this OTVI position in real-time on the Real Time Feed of the ZYX Buy Change Alert zyx change method http://thearorareport.com/sub